Meiyin Zhang Selected Research

Neoplasms (Cancer)

12/2023	Ezetimibe Induces Paraptosis through Niemann-Pick C1-like 1 Inhibition of Mammalian-Target-of-Rapamycin Signaling in Hepatocellular Carcinoma Cells.
11/2020	Integrated analysis of a competing endogenous RNA network reveals an 11-lncRNA prognostic signature in ovarian cancer.
1/2019	miR-215 suppresses papillary thyroid cancer proliferation, migration, and invasion through the AKT/GSK-3β/Snail signaling by targeting ARFGEF1.
11/2018	MicroRNA‑342‑3p suppresses proliferation and invasion of nasopharyngeal carcinoma cells by directly targeting Cdc42.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Meiyin Zhang Research Topics

Disease

4	Neoplasms (Cancer) 12/2023 - 11/2018
4	Ovarian Neoplasms (Ovarian Cancer) 07/2023 - 12/2019
3	Neoplasm Metastasis (Metastasis) 01/2021 - 11/2018
1	Hepatocellular Carcinoma (Hepatoma) 12/2023
1	Carcinogenesis 01/2021
1	Head and Neck Neoplasms (Head and Neck Cancer) 04/2019
1	Nasopharyngeal Carcinoma 11/2018

Drug/Important Bio-Agent (IBA)

2	Circular RNAIBA 01/2021 - 12/2019
2	MicroRNAs (MicroRNA)IBA 01/2019 - 11/2018
1	Ezetimibe (Zetia)FDA Link 12/2023
1	TOR Serine-Threonine KinasesIBA 12/2023
1	CateninsIBA 07/2023
1	Glucose (Dextrose)FDA LinkGeneric 01/2021
1	Messenger RNA (mRNA)IBA 01/2021
1	E2F2 Transcription FactorIBA 01/2021
1	ELAV-Like Protein 1IBA 01/2021
1	Long Noncoding RNAIBA 11/2020
1	Competitive Endogenous RNAIBA 11/2020
1	Biomarkers (Surrogate Marker)IBA 01/2019
1	rho GTP-Binding Proteins (rho GTP-Binding Protein)IBA 11/2018
1	RNA (Ribonucleic Acid)IBA 11/2018

Therapy/Procedure

1	Radiotherapy 12/2023
1	Drug Therapy (Chemotherapy) 12/2023
1	Molecular Targeted Therapy 04/2019